News & Articles

Next-generation system combines ion mobility, advanced fragmentation, and imaging to enable deeper insight into disease biology

New Orbitrap platforms, AI-enabled software and integrated workflows deliver deeper insight, more confident development decisions and stronger results across complex scientific markets

Day 2 at ASMS brings a full schedule of oral sessions, posters and exhibits, networking events, and a major moment for industry recognition, with SelectScience announcing its 2026 Scientists’ Choice Award winners alongside the conference

Catch up on the insights shaping the future of life sciences and automation

ASMS 2026 gets fully underway today, with a packed schedule of oral sessions, the opening of posters and exhibits, and a full lineup of exhibitor technology announcements expected

New software platform improves performance, usability, and mutant analysis capabilities for structural biology and proteomics research

Novel mass spectrometry based assay enables scalable, label free analysis of drug target interactions

New mass spectrometry platforms, combined with AI-driven analytics and scalable proteomics solutions, help scientists turn complex biology into actionable insights across research and drug development

Proteograph platform supports large-scale proteomics and AI-driven biomarker discovery workflows

Strengthening local presence and customer support in a high-growth life sciences market

Automated imaging systems support real-time analysis of spheroids and organoids in scalable drug discovery workflows

Proposed regulatory approach aims to enable earlier patient access and support innovative trial designs

Collaboration expands access to predictive AI tools within existing data management workflows

Lumipulse G pTau 217 Plasma test supports identification of amyloid pathology in patients with cognitive decline

Hear how the Program of Glyco-Immunology and Oncology (PGIO) is deciphering cancer’s ‘glyco code’ to pave the way for more precise diagnostics and next generation immunotherapies

Dr. Michael Kiebish of BPGbio shares insight into its AI-powered NAi Interrogative Biology Platform and discusses the growing importance of multiomic data

In research conducted in mice, scientists identified a trio of existing medicines as promising candidates for treating a rare and severe form of infant leukemia caused by a genetic changed called KMT2A::AFF1

Drug Discovery USA 2026 to focus on emerging multifunctional small molecule and biologic approaches to drug difficult targets

Collaboration aims to discover and develop antibodies against multiple therapeutic targets designated by Merck

The U.S. FDA has cleared the Investigational New Drug (IND) application for ABSK061, a highly selective small-molecule FGFR2/3 inhibitor, for the treatment of children with achondroplasia (ACH)

Dr. Becky Upton, President of Pistoia Alliance, looks to the future of lab innovation in this guest editorial

Injecting nivolumab directly into precancerous oral lesions led to reduction in lesion size and allowed some patients to avoid surgery

Co-occurrence of myocarditis with myositis and myasthenia gravis may also increase risk of death

Data presented at the AACR 2026 revealed a 44% reduction and growing urban concentration of U.S. phase I NSCLC trial sites between 2020 and 2024

All patients were negative for minimal residual disease, and no patients experienced progression to active multiple myeloma during the median 15.3 months of follow-up